Update on Novel Medications: GERD Treatment and Menopausal Symptoms

One of the recent FDA-approved medications discussed in the podcast was Veneprasan, a potassium competitive acid blocker used for refractory GERD. It showed efficacy in severe erosive esophagitis. Another medication, Fezilinitant, a neurokinin receptor blocker, was highlighted for menopausal symptom treatment due to its effectiveness in reducing hot flashes. The session also covered RSV vaccines, with Moderna developing an mRNA vaccine. The fourth FDA-approved drug, Jeparone, a 5-HT1A partial agonist, offers a potential alternative for depression treatment without weight gain or sexual side effects.